Haemorheology and the inflammatory process

Clinical Hemorheology and Microcirculation

Volumn 19, Issue 2, 1998, Pages 129-132

  Rampling, M W ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Acute phase response; Fibrinogen; Haemorheology; Inflammatory response

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; BRADYKININ; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIN; FIBRINOGEN; HAPTOGLOBIN; HISTAMINE; INTERLEUKIN 1; KININ; NICOTINAMIDE; NITRIC OXIDE; OROSOMUCOID; PENTOXIFYLLINE; PLASMA PROTEIN; PROSTAGLANDIN; PROTEINASE; TUMOR NECROSIS FACTOR;

ACUTE PHASE RESPONSE; ARTICLE; BLOOD; BLOOD RHEOLOGY; BLOOD VESSEL PERMEABILITY; BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; HEMOCONCENTRATION; HEMODYNAMICS; HUMAN; INFLAMMATION; TISSUE INJURY; VASODILATATION;

HEMORHEOLOGY; HUMANS; INFLAMMATION;

EID: 0031738875     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. D.A. Willoughby, Inflammation-mediators and mechanisms, Br. Med. Bul. 43 (1987), 256-371.
2. P. Milner, A. Loesch and G. Burnstock, Plastic expression of endothelial vasoactive agents, in: Vascular Endothelium, G.V.R. Born and C.J. Schwartz, eds, Schattauer, Stuttgart, 1997, pp. 243-260.
3. E. Ascheim and B.W. Zweifach, Quantitative studies of protein and water shifts during inflammation, Am. J. Physiol. 102 (1962), 554-558.
4. C. Dosquet and J.-L. Wautier, Blood monocyte adhesion to vascular endothelial cells: implications in vascular pathology, Clin. Hemorheol. 12 (1992), 817-825.
5. B. Furie and B.C. Furie, Leukocyte crosstalk and the vascular wall, Thromb. Haemostas. 78 (1997), 306-309.
6. R.R. Thiagarajan, R.K. Winn and J.M. Marian, The role of leukocyte and endothelial adhesion molecules in ischemia: reperfusion injury, wall, Thromb. Haemostas. 78 (1997), 310-314.
7. J.T. Whicher and P.A. Dieppe, Acute phase proteins, Clin. Immunol. Allergy 5 (1985), 425-446.
8. L.A. Hernandez, M.B. Grisham, B. Twohig, K.E. Arfors, J.M. Harlan and N. Granger, Role of neutrophils in ischemia-reperfusion-induced microvascular injury, Am. J. Physiol. 253 (1987), H699-H703.
9. D.J. Honess, Y. Kitamoto, M.W. Rampling and N.M. Bleehen, Nicotinamide and pentoxifylline increase human leucocyte filterability: a possible mechanism for reduction of acute hypoxia, Br. J. Cancer 74 (1996), S236-S240.
10. G.D.O. Lowe, Rheology of disease, in: Clinical Blood Rheology, Vol. II, G.O.D. Lowe, ed., CRC Press, Boca Raton, 1988, pp. 89-111.
11. G.D.O. Lowe, Plasma and blood viscosity, in: Clinical Blood Rheology, Vol. I, G.O.D. Lowe, ed., CRC Press, Boca Raton, 1988, pp. 11-44.
12. M.W. Rampling, Red cell aggregation and yield stress, in: Clinical Blood Rheology, Vol. I, G.O.D. Lowe, ed., CRC Press, Boca Raton, 1988, pp. 45-64.
13. A.H. Henschen, Human fibrinogen exists as over one million nonidentical molecules, J. Prot. Chem. 13 (1994), 504-505.
14. B. Holm, D.W.T. Neilsen, P. Keirulf and H.C. Godal, Purification and characterisation of three fibrinogens with different molecular weights obtained from normal human plasma, Thromb. Res. 37 (1985), 165-176.
15. B. Holm and H.C. Godal, Evidence that changes in fibrinogen quality during acute phase reactions are of major importance for the amount of heparin precipitable fraction (HPF), Thromb. Res. 39 (1985), 449-458.
16. W. Nieuwenhuizen, Biochemistry and measurement of fibrinogen, Eur. Heart J. 16(A) (1995), 6-10.
17. M. Roberts, K. Balderston and M.W. Rampling, Fibrinogen heterogeneity and the acute phase response, in: Proc. European Congress on Clinical Haemorheology, Lisbon, 29 June-2 July 1997.
18. T. Khodabandehlou, C. Le Dévéhat and M. Razavian, Impaired function of fibrinogen: consequences on red cell aggregation in diabetes mellitus, Clin. Hemorheol 16 (1996), 303-312.
19. R. Schpizt-Droz, C. Bucherer, J. Ladjouzi, C. Lacombe and J.C. Lelièvre, Are there two kinds of fibrinogen in diabetic plasma as suggested by a multivariate analysis?, Clin. Hemorheol. 11 (1991), 387-396.
20. D.F. Bainton, Developmental biology of neutrophils and eosinophils, in: Inflammation: Basic Principles and Clinical Correlates, J.I. Gallin, I.M. Goldstein and R. Snyderman, eds, Raven Press, New York, 1992, pp. 303-324.
21. N.Z. Ertan, M.W. Rampling, M.J. Pearson, C.P. Winlove, P.M. Gribbon and D. Davidson, Time-dependent effects of trypsin treatment of human red cells, Clin. Hemorheol. 13 (1993), 473-480.
22. M.W. Rampling and P.J. Pearson, Enzymatic degradation of the red cell surface and its effects on rouleaux formation, Clin. Hemorheol. 14 (1994), 531-538.
23. M.E. Rogers, D.T. Williams, R. Niththyananthan, M.W. Rampling, K.E. Heslop and D.G. Johnson, Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes, Clin. Sci. 82 (1992), 309-313.
24. P.R. Woodhouse, K.T. Khan, M. Plummer, A. Foley and T.W. Meade, Seasonal variations of plasma fibrinogen and Factor VII activity in the elderly: winter infections and death from cardiovascular disease, Lancet 343 (1994), 435-439.